Processes like the HTA review represent the hijacking of public health by officials and a small group of privileged stakeholders who then use the instruments of government to impose an all-pervasive conformity that punishes dissent by exclusion.
-
Latest News
Budget outcome confirms double-digit growth for pharmaceutical spend
The 2022-23 Final Budget Outcome has revealed that spending on the pharmaceutical services and benefits sub-function was $1 billion lower than expected in May but still 14 per cent higher than last year.
-
Latest News These major processes related to public health programs can not continue in this way September 25, 2023
-
Latest News Hospital pharmacy launches new professional recognition program September 25, 2023The Society of Hospital Pharmacists of Australia has announced a new recognition program that aims to transform pharmacy practice in Australia and New Zealand.
-
Latest News This farcical inquiry effectively puts major pandemic decisions beyond reach September 22, 2023This matters because so many people responsible for decisions during the pandemic are beyond the powers of this inquiry, such as those responsible for major decisions on COVID-19 vaccines, including retired health minister Greg Hunt, former health department secretary Professor Brendan Murphy AC, and ex-TGA head John Skerritt.
-
Podcast The 'Week in Review' Podcast - 22 September September 22, 2023A special guest joins the podcast to discuss the lost opportunity to celebrate a significant anniversary for the PBS and even reshape perceptions of the program. The government has also released its Final Budget Outcome, revealing strong growth in pharmaceutical spending and a problem with invoicing companies for rebates.
-
Latest News AusBiotech announces the departure of CEO September 21, 2023AuBiotech CEO Lorraine Chiroiu has announced that she will depart the organisation in December after five years leading the peak representative body for Australia's biotechnology sector.
-
Latest News National and Labour commit to addressing Pharmac's fiscal 'cliff' September 22, 2023Pharmac has featured again during New Zealand's election campaign with the future of its potential fiscal 'cliff' the focus of debate.
-
Latest News Moderna launches 'Welcome to the mRNAge' brand campaign September 22, 2023The company said the 'Welcome to the mRNAge' campaign will include a range of assets that aim to create an approachable and inclusive connection with the audience, to expand the understanding of the possibilities of mRNA technology.
-
Latest News Australia's health department releases information on international HTA collaboration September 21, 2023The Department of Health and Aged Care has re-published a communique released by the UK's National Institute for Health and Care Excellence last month on the international health technology assessment collaboration.
-
Latest News Joint congressional attempt to mitigate the impact of new price-setting power September 21, 2023Two US congressmen, one Republican and the other a Democrat, have moved to amend the Biden administration’s Inflation Reduction Act with the goal of protecting investment in new therapies for rare diseases.
-
Australian Biotech BioCurate and Takeda renew alliance to accelerate discoveries September 20, 2023BioCurate, the independently operated joint venture between The University of Melbourne and Monash University, has announced the renewal of its partnership with Takeda.
-
Other Health NSW launches special commission of inquiry into healthcare funding September 20, 2023The New South Wales government has launched its Special Commission of Inquiry into Healthcare Funding and is now inviting submissions from health sector representative bodies, service providers, health staff and practitioners, and the general public.
-
Latest News Everything in the policy 'soup' is connected and everything happens for a reason September 20, 2023In publishing a two-part Budget analysis for the pharmaceuticals services and benefits sub-function, BioPharmaDispatch has sought to highlight a developing factor that will feed into an already complex environment for the PBS.
-
Australian Biotech AusBiotech lauds Australian-discovered drug after US FDA approval September 20, 2023AusBiotech has described the US FDA approval of GSK's OJJAARA (momelotinib) as a "huge moment" for Australia's biotechnology community.
-
Latest News Moderna announces the appointment of medical director for Australia and NZ September 19, 2023Moderna has announced the appointment of Dr Andrea McCracken as a medical director for Australia and New Zealand.
-
Latest News Moderna marks halfway point in construction of mRNA manufacturing facility September 19, 2023Moderna has celebrated a halfway milestone for its Australian mRNA vaccine manufacturing facility nine months after breaking ground on the construction site in the Monash Technology Precinct in Melbourne.
-
Latest News A one-off annual impact when it comes to spending growth is unlikely September 19, 2023In the 2020-21 Budget, the government forecast spending on the sub-function of $15.104 billion in 2023-24. This has steadily risen and was $19.106 billion in the 2023-24 Budget, matching what was seen for 2022-23.
-
Latest News Clinicians urged to access training on voluntary assisted dying September 19, 2023A group of people with expertise in Voluntary Assisted Dying have suggested that all cancer specialists and GPs should undertake training for end-of-life decisions by patients.
-
Latest News Final Budget Outcome will confirm the extent of topline PBS growth September 18, 2023As we await the 2022-23 Final Budget Outcome, an analysis of forecast government spending on the pharmaceuticals sub-function reveals a potentially significant spike in topline growth. It also shows how Budget estimates for low or no growth can be very misleading because of what they do not include.
-
Latest News Patients win reprieve with Novo Nordisk listing a new form of insulin aspart September 17, 2023“Novo Nordisk heard loud and clear the impact to the 15,000 Australians living with diabetes who depended on FIASP, if FIASP was no longer available on the PBS. We are pleased that patients can continue accessing this treatment on the PBS,” said Cem Ozenc, corporate vice president and general manager of Novo Nordisk Oceania.
Australian Biotech
-
US FDA grants conditional approval to the brand name of Dimerix's DMX-200
September 25, 2023 -
BioCurate and Takeda renew alliance to accelerate discoveries
September 20, 2023 -
AusBiotech lauds Australian-discovered drug after US FDA approval
September 20, 2023 -
Radiopharm Theranostics announces clinicaldData presentation for 68Ga-Trivehexin
September 18, 2023 -
Adherium announces new partnership with leading US allergy and asthma group
September 18, 2023
Other Health
-
HBF reports revenue growth with expanding membership outside WA
September 25, 2023 -
NSW launches special commission of inquiry into healthcare funding
September 20, 2023 -
Medibank's Amplar Home Health accredited for another three years
September 20, 2023 -
HCF has announced the national roll-out of a QR-based digital membership card
September 20, 2023 -
nib joins Dylan Alcott's 'Shift 20' to change how disability is represented in advertising
September 18, 2023
Latest Video
New Stories
-
HBF reports revenue growth with expanding membership outside WA
September 25, 2023 - - Other Health -
US FDA grants conditional approval to the brand name of Dimerix's DMX-200
September 25, 2023 - - Australian Biotech -
Budget outcome confirms double-digit growth for pharmaceutical spend
September 25, 2023 - - Latest News -
These major processes related to public health programs can not continue in this way
September 25, 2023 - - Latest News -
Hospital pharmacy launches new professional recognition program
September 25, 2023 - - Latest News -
The 'Week in Review' Podcast - 22 September
September 22, 2023 - - Podcast -
National and Labour commit to addressing Pharmac's fiscal 'cliff'
September 22, 2023 - - Latest News